Newsy's Latest Health News

The Trump administration has introduced new guidelines to expedite COVID-19 vaccinations, expanding eligibility to all Americans over 65 and those with underlying conditions. The government will no longer reserve second doses, aiming to increase vaccine supply. Vaccination sites will include community health centers and pharmacies. Moderna plans to start trials for children aged 1-11, with data expected in 2022, while trials for ages 12 and up are underway. The video concludes with thanks to Kaiser Health News.

What new insight or understanding did you gain from this video?